300
Participants
Start Date
February 10, 2020
Primary Completion Date
August 7, 2020
Study Completion Date
January 5, 2021
botulinum toxin
neuromodulator to be injected in the GL region
Placebo
Placebo to be injected in the GL area
Robert Schwarcz, MD, PC, New York
Sachin M Shridharani, MD, New York
Maryland Dermatology, Laser Skin & Vein, Hunt Valley
Wilmington Dermatology Center, PLLC, Wilmington
The Practice of Brian S Biesman, MD, Nashville
Tennessee Clinical Research Center, Nashville
Skin Specialist, PC, Omaha
Etre Cosmetic Dermatology and Laser Center, New Orleans
Dallas Center for Dermatology & Aesthetics, Dallas
Integrated Aesthetics, Inc, Spring
Austin Institute for Clinical Research, Inc., Pflugerville
\Ablon Skin Institute and Research Center, Manhattan Beach
Moradi MD, Vista
Sweat Clinics of Canada, Toronto
Lead Sponsor
Galderma R&D
INDUSTRY